Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK656 (GSK3036656) shows potent inhibition of Mycobacterium tuberculosis (Mtb) leucyl-tRNA synthetase (LeuRS) (IC50 = 0.20 μM) which has potential for the treatment of tuberculosis [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 2,270.00 | |
50 mg | 8-10 weeks | $ 2,980.00 | |
100 mg | 8-10 weeks | $ 4,000.00 |
Description | GSK656 (GSK3036656) shows potent inhibition of Mycobacterium tuberculosis (Mtb) leucyl-tRNA synthetase (LeuRS) (IC50 = 0.20 μM) which has potential for the treatment of tuberculosis [1]. |
Synonyms | GSK656 HCl, GSK 3036656, GSK656, GSK-3036656, GSK-656, GSK 656 |
Molecular Weight | 257.48 |
Formula | C10H13BClNO4 |
CAS No. | 2131798-12-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK-3036656 free base 2131798-12-2 GSK656 HCl GSK 3036656 GSK656 GSK-3036656 GSK-656 GSK 656 GSK3036656 inhibitor inhibit